Search research articles
Contact Us
Filters
Showing results (221-230 of 267) with videos related to
Page
of 27
Sort By:
Brain : a Journal of Neurology
|
March 23, 2021
Deep grey matter injury in multiple sclerosis: a NAIMS consensus statement
Daniel Ontaneda, Praneeta C Raza, Kedar R Mahajan, et al.
Epidemiology (Cambridge, Mass.)
|
January 11, 2023
Prenatal Exposure to Per- and Polyfluoroalkyl Substances and Childhood Autism-related Outcomes
Jennifer L Ames, Mohamad Burjak, Lyndsay A Avalos, et al.
Nature Reviews. Neurology
|
November 12, 2016
The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative
Pascal Sati, Jiwon Oh, R Todd Constable, et al.
The Lancet. Neurology
|
June 17, 2021
2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis
Mike P Wattjes, Olga Ciccarelli, Daniel S Reich, et al.
Annals of Clinical and Translational Neurology
|
June 30, 2025
Cervical Spinal Cord Magnetization Transfer Ratio and Its Relationship With Clinical Outcomes in Multiple Sclerosis
Lisa Eunyoung Lee, Julien Cohen-Adad, Irene M Vavasour, et al.
International Journal of MS Care
|
November 12, 2020
An International Standardized Magnetic Resonance Imaging Protocol for Diagnosis and Follow-up of Patients with Multiple Sclerosis: Advocacy, Dissemination, and Implementation Strategies
Lori Saslow, David K B Li, June Halper, et al.
Environmental Research
|
March 9, 2026
Gestational exposure to organophosphate ester flame retardants and child growth in weight, height, and body mass index at age 2-10 years: the Environmental influences on Child Health Outcomes Program
Anne P Starling, Xuan Li, Jennifer L Ames, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
November 26, 2022
Comparative effectiveness of cladribine tablets versus other oral disease-modifying treatments for multiple sclerosis: Results from MSBase registry
Tim Spelman, Serkan Ozakbas, Raed Alroughani, et al.
Neurodegenerative Disease Management
|
June 8, 2023
A plain language summary on the effectiveness of cladribine tablets compared with other oral treatments for multiple sclerosis: results from the MSBase registry
Tim Spelman, Serkan Ozakbas, Raed Alroughani, et al.
Annals of Clinical and Translational Neurology
|
February 22, 2021
Manifestations and impact of the COVID-19 pandemic in neuroinflammatory diseases
Seth N Levin, Shruthi Venkatesh, Katie E Nelson, et al.
Page
of 27
Search research articles
Search
Showing results (221-230 of 267) with videos related to
Sort By:
Page
of 27
Brain : a Journal of Neurology
|
March 23, 2021
Deep grey matter injury in multiple sclerosis: a NAIMS consensus statement
Daniel Ontaneda, Praneeta C Raza, Kedar R Mahajan, et al.
Epidemiology (Cambridge, Mass.)
|
January 11, 2023
Prenatal Exposure to Per- and Polyfluoroalkyl Substances and Childhood Autism-related Outcomes
Jennifer L Ames, Mohamad Burjak, Lyndsay A Avalos, et al.
Nature Reviews. Neurology
|
November 12, 2016
The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative
Pascal Sati, Jiwon Oh, R Todd Constable, et al.
The Lancet. Neurology
|
June 17, 2021
2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis
Mike P Wattjes, Olga Ciccarelli, Daniel S Reich, et al.
Annals of Clinical and Translational Neurology
|
June 30, 2025
Cervical Spinal Cord Magnetization Transfer Ratio and Its Relationship With Clinical Outcomes in Multiple Sclerosis
Lisa Eunyoung Lee, Julien Cohen-Adad, Irene M Vavasour, et al.
International Journal of MS Care
|
November 12, 2020
An International Standardized Magnetic Resonance Imaging Protocol for Diagnosis and Follow-up of Patients with Multiple Sclerosis: Advocacy, Dissemination, and Implementation Strategies
Lori Saslow, David K B Li, June Halper, et al.
Environmental Research
|
March 9, 2026
Gestational exposure to organophosphate ester flame retardants and child growth in weight, height, and body mass index at age 2-10 years: the Environmental influences on Child Health Outcomes Program
Anne P Starling, Xuan Li, Jennifer L Ames, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
November 26, 2022
Comparative effectiveness of cladribine tablets versus other oral disease-modifying treatments for multiple sclerosis: Results from MSBase registry
Tim Spelman, Serkan Ozakbas, Raed Alroughani, et al.
Neurodegenerative Disease Management
|
June 8, 2023
A plain language summary on the effectiveness of cladribine tablets compared with other oral treatments for multiple sclerosis: results from the MSBase registry
Tim Spelman, Serkan Ozakbas, Raed Alroughani, et al.
Annals of Clinical and Translational Neurology
|
February 22, 2021
Manifestations and impact of the COVID-19 pandemic in neuroinflammatory diseases
Seth N Levin, Shruthi Venkatesh, Katie E Nelson, et al.
Page
of 27